查詢結果分析
來源資料
相關文獻
- Intra and Extrahepatic Cholangiocarcinomas: Clinical Experience with 101 Consecutive Cases in a Single Institution
- 肝外膽道癌
- Histomorphometric Evaluation of Mucin Content in Stone-Containing Intrahepatic Bile Ducts
- Pathology of Hepatolithiasis
- 再論肝內結石與肝管癌
- 氣球導管擴張術治療肝內肝管狹窄及膽道腸吻合口狹窄
- 肝外膽道修補手術
- 肝細胞癌病人之肝外循環血管
- 肝葉切除術以治療左肝內結石症
- Choledochoscopic Heat-Probe Therapy: An Adjunctive Palliative Treatment for Intrahepatic Cholangiocarcinoma With Hepatolithiasis
頁籤選單縮合
題 名 | Intra and Extrahepatic Cholangiocarcinomas: Clinical Experience with 101 Consecutive Cases in a Single Institution=肝內及肝外膽道癌--一個單獨醫療機構連續101病例之臨床經驗 |
---|---|
作 者 | 張耀仁; 李明哲; 伍超群; 鄭敦仁; 陳華宗; | 書刊名 | 慈濟醫學 |
卷 期 | 15:2 2003.04[民92.04] |
頁 次 | 頁75-83 |
分類號 | 416.247 |
關鍵詞 | 膽道癌; 肝內; 肝外; Cholangiocarcinoma; Intrahepatic; Extrahepatic; |
語 文 | 英文(English) |
中文摘要 | 目的:評估肝內或肝外膽道癌病人之臨床特徵及外科治療之成果。病人與方法:於15年間臨床上診斷為肝內或肝外膽道癌連續101位病人依位置分為四類:肝內、肝門、中段及末段膽道癌。病人之臨床表現、腫瘤標示、診斷方法及腫瘤分期均予以統計分析。同時並比較各類病人之手術併發症及存活比率。結果:膽道結石在這些病人中並不罕見,約39%的肝內膽道癌病人併存有肝內結石。在肝內膽道癌病人中最常見之症狀為腹部疼痛,而肝門及末段膽道癌病人最常見之症狀則為黃疸。所有膽道癌中共有三位總膽管囊腫病人。約73%的病人為癌症分期第三期或第四期的病人。腫瘤切除率為37%而手術死亡率為8.1%,術後併發症最常見者為傷口感染及膽汁滲漏。所有病人的五年存活率為6%,中位存活期為四個月。治癒性腫瘤切除之一、三、五年存活率分別為肝內膽道癌83.33%、34.88%及34.72%,肝門膽道癌14.44%、9.63%及4.81%,而末段膽道癌則為76.38%、22.27%及19.76%。治癒性比非治癒性腫瘤切除之術後存活率佳。結論:積極手術治療以確保乾淨的切除邊緣,將可改善切除病人之存活比率。 |
英文摘要 | Objective: To evaluate the clinical characteristics and surgical results in patients with intra or extrahepatic cholangiocarcinoma. Patients and Methods: One hundred and one consecutive patients clinically diagnosed with intra or extrahepatic cholangiocarcinoma in a 15-year period were divided into four groups, i.e., intrahepatic, hilar, mid third and distal duct cholangiocarcinomas. The patients' climical characteristics, expression of tumor markers, diagnostic tools and tumor stagings were reviewed. Operative complications and survival rates were analyzed and compared in each group. Results: Biliary tract stones were not uncommon in this study. Thirty-nine percent of the intrahepatic group had intrahepatic stones. The most common symptom in the intrahepatic type was abdominal pain while jaundice was most common in the hilar and distal types of cholangiocarcinomas. Three patients had choledocal cyst disease. Most patients (73%) were in stage III or stage IV. The resectability rate was 37% (37 patients) with a surgical mortality of 8.1% (3 patients). Wound infection and bile leak were the most common complications postoperatively. The overall 5-year actuarial survival rate was 6% and median survival 4 months. The 1-year, 3-year survival rates of non-curatively resected patients were 11.11%, 7.60%, 1.75% for the ICCA (intrahepatic cholangiocarcinoma) group, 0%, 0%, 0% for the HCCA (hilar cholangiocarcinoma) group and 37.5%, 11.88%, 8.75% for the DCCA (distal duct cholangiocarcinoma) group. The curatively resected patients had significantly better survival than the non-curatively resected patients in each group, with 1-year, 3-year and 5-year survival rates of 83.33%, 34.88% and 34.72% in the ICCA group, 14.44%, 9.63% and 4.81% in the HCCA group and 76.38%, 22.27% and 19.76% in the DCCA group. Conclusions: Survival after curative resection was significantly better than that after palliative procedures in the ICCA and DCCA group. Aggressive surgery in resect6able cases is suggested in the MCCA group, in order to improve survival. |
本系統中英文摘要資訊取自各篇刊載內容。